FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: Sara Lee

Sort
E.g., 2013-06-19
E.g., 2013-06-19
Enter a comma separated list of user names.

Sara Lee Corp (NYSE:SLE) is a global manufacturer and marketer of brand-name products for consumers globally focused primarily on the meats, bakery, beverage and household products categories. Sara Lee Corp witnessed volume of 22.75 million shares during last trade however it holds an average trading capacity of 4.74 million shares.

Sara Lee Corp (NYSE:SLE) is a global manufacturer and marketer of brand-name products for consumers globally focused primarily on the meats, bakery, beverage and household products categories. Sara Lee Corp achieved its new 52 week high price of $22.04 where it was opened at $21.24 up 1.44 points or 7.06% by closing at $21.83.

Sara Lee Corp (NYSE:SLE) is a global manufacturer and marketer of brand-name products for consumers globally focused primarily on the meats, bakery, beverage and household products categories. Sara Lee Corp achieved its new 52 week high price of $19.96 where it was opened at $19.25 UP 0.83 points or +4.36% by closing at $19.85.

Sara Lee Corp. (NYSE:SLE) announced that its presentation at the Consumer Analyst Group of New York’s (CAGNY) annual conference will be broadcast live via the Internet at 11:30 a.m. CST on Tuesday, Feb. 22, 2011. The live webcast can be accessed at www.saralee.com and will feature presentations by Marcel Smits, chief executive officer, and Mark Garvey, chief financial officer, Sara Lee Corp.

Sara Lee Shares Should Rally This Week

Posted by Navivest on January 10th, 2011

Shares of food maker, Sara Lee (SLE) should rally this week, on active takeover chatter.

10 Best Stocks of the Decade

Posted by Guru on January 6th, 2011

Gone are the days of buy-and-hold investing. Stock picking was the strategy for the past decade, and these 10 companies were the best performers in the S&P 500.

Intuitive Surgical
Stock picking trumped buy-and-hold over the past decade, reversing the reigning investment strategy that encouraged investors to pile into passively managed index funds.

Power3 Medical Products, Inc. (OTCBB:PWRM), a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, disclosed that it has signed a definitive agreement to acquire all of the stock of Rozetta-Cell Life Sciences, Inc.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

Pages

ADVERTISE WITH US